The GWAS Catalog showed various associations with UBE2J2, including many cardiometabolic measures (e.g., body mass index, systolic blood pressure and coronary heart disease), autoimmune diseases (e.g., inflammatory bowel diseases and ulcerative colitis), CRC and others, suggesting UBE2J2 gene expression could have a downstream impact on CRC. This evidence concerns the gene UBE2J2 and coronary artery disorder.